PlainRecalls
FDA Drug Moderate Class II Terminated

Neomycin Sulfate Tablets, USP 500 mg , 100-count bottles, Rx only, Distributed by: TEVA PHARMACEUTICALS USA, INC North Wales, PA 19454, NDC 0093-1177-01

Reported: September 7, 2022 Initiated: August 23, 2022 #D-1473-2022

Product Description

Neomycin Sulfate Tablets, USP 500 mg , 100-count bottles, Rx only, Distributed by: TEVA PHARMACEUTICALS USA, INC North Wales, PA 19454, NDC 0093-1177-01

Reason for Recall

CGMP Deviations: A foreign matter identified as teflon was found in the Active Pharmaceutical Ingredient (API) used in the manufacture of Neomycin Sulfate Tablets, USP 500 mg.

Details

Distribution
Nationwide within the United States
Location
Parsippany, NJ

Frequently Asked Questions

What product was recalled?
Neomycin Sulfate Tablets, USP 500 mg , 100-count bottles, Rx only, Distributed by: TEVA PHARMACEUTICALS USA, INC North Wales, PA 19454, NDC 0093-1177-01. Recalled by Teva Pharmaceuticals USA Inc.
Why was this product recalled?
CGMP Deviations: A foreign matter identified as teflon was found in the Active Pharmaceutical Ingredient (API) used in the manufacture of Neomycin Sulfate Tablets, USP 500 mg.
Which agency issued this recall?
This recall was issued by the FDA Drug on September 7, 2022. Severity: Moderate. Recall number: D-1473-2022.